[HTML][HTML] Exosomes in the lung cancer microenvironment: Biological functions and potential use as clinical biomarkers
R Qi, Y Zhao, Q Guo, X Mi, M Cheng, W Hou… - Cancer Cell …, 2021 - Springer
Lung cancer is one of the most common malignant tumours worldwide. however, emerging
immunotherapy and targeted therapies continue to show limited efficacy. In the search for …
immunotherapy and targeted therapies continue to show limited efficacy. In the search for …
[HTML][HTML] Exosomes in the lung cancer microenvironment: biological functions and potential use as clinical biomarkers
R Qi, Y Zhao, Q Guo, X Mi, M Cheng, W Hou… - Cancer Cell …, 2021 - ncbi.nlm.nih.gov
Lung cancer is one of the most common malignant tumours worldwide. however, emerging
immunotherapy and targeted therapies continue to show limited efficacy. In the search for …
immunotherapy and targeted therapies continue to show limited efficacy. In the search for …
Exosomes in the lung cancer microenvironment: biological functions and potential use as clinical biomarkers.
R Qi, Y Zhao, Q Guo, X Mi, M Cheng… - Cancer Cell …, 2021 - search.ebscohost.com
Lung cancer is one of the most common malignant tumours worldwide. however, emerging
immunotherapy and targeted therapies continue to show limited efficacy. In the search for …
immunotherapy and targeted therapies continue to show limited efficacy. In the search for …
Exosomes in the lung cancer microenvironment: biological functions and potential use as clinical biomarkers
R Qi, Y Zhao, Q Guo, X Mi, M Cheng… - Cancer cell …, 2021 - pubmed.ncbi.nlm.nih.gov
Lung cancer is one of the most common malignant tumours worldwide. however, emerging
immunotherapy and targeted therapies continue to show limited efficacy. In the search for …
immunotherapy and targeted therapies continue to show limited efficacy. In the search for …
[HTML][HTML] Exosomes in the lung cancer microenvironment: biological functions and potential use as clinical biomarkers
R Qi, Y Zhao, Q Guo, X Mi, M Cheng… - Cancer Cell …, 2021 - cancerci.biomedcentral.com
Lung cancer is one of the most common malignant tumours worldwide. however, emerging
immunotherapy and targeted therapies continue to show limited efficacy. In the search for …
immunotherapy and targeted therapies continue to show limited efficacy. In the search for …
[PDF][PDF] Exosomes in the lung cancer microenvironment: biological functions and potential use as clinical biomarkers
R Qi, Y Zhao, Q Guo, X Mi, M Cheng, W Hou, H Zheng… - 2021 - scholar.archive.org
Lung cancer is one of the most common malignant tumours worldwide. however, emerging
immunotherapy and targeted therapies continue to show limited efficacy. In the search for …
immunotherapy and targeted therapies continue to show limited efficacy. In the search for …
Exosomes in the lung cancer microenvironment: biological functions and potential use as clinical biomarkers.
R Qi, Y Zhao, Q Guo, X Mi, M Cheng, W Hou… - Cancer Cell …, 2021 - go.gale.com
Lung cancer is one of the most common malignant tumours worldwide. however, emerging
immunotherapy and targeted therapies continue to show limited efficacy. In the search for …
immunotherapy and targeted therapies continue to show limited efficacy. In the search for …
Exosomes in the lung cancer microenvironment: biological functions and potential use as clinical biomarkers.
R Qi, Y Zhao, Q Guo, X Mi, M Cheng, W Hou… - Cancer Cell …, 2021 - europepmc.org
Lung cancer is one of the most common malignant tumours worldwide. however, emerging
immunotherapy and targeted therapies continue to show limited efficacy. In the search for …
immunotherapy and targeted therapies continue to show limited efficacy. In the search for …
Exosomes in the lung cancer microenvironment: biological functions and potential use as clinical biomarkers
R Qi, Y Zhao, Q Guo, X Mi, M Cheng… - Cancer Cell …, 2021 - search.proquest.com
Lung cancer is one of the most common malignant tumours worldwide. however, emerging
immunotherapy and targeted therapies continue to show limited efficacy. In the search for …
immunotherapy and targeted therapies continue to show limited efficacy. In the search for …
[PDF][PDF] Exosomes in the lung cancer microenvironment: biological functions and potential use as clinical biomarkers
R Qi, Y Zhao, Q Guo, X Mi, M Cheng, W Hou, H Zheng… - 2021 - cancerci.biomedcentral.com
Lung cancer is one of the most common malignant tumours worldwide. however, emerging
immunotherapy and targeted therapies continue to show limited efficacy. In the search for …
immunotherapy and targeted therapies continue to show limited efficacy. In the search for …